🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📬Today, I received the acceptance of my application to join the IBCG. It is a great honor to be part of this group of excellence, and I am very excited to start collaborating to achieve the best advancements in #bladdercancer. 🎖️Really honored about this opportunity!

Gustavo Villoldo IBCG blatam uro Mario I Fernandez Welcome aboard!

#UroAstellas en #SMU24 SMU México Linden MD DR CARVAJAL zaelsantana Emmanuel Rosas Nava Gustavo Villoldo Especial reconocimiento a los Residentes SMU 🇲🇽 que participaron con tanto entusiasmo y a todo el profesorado de este gran foro académico. #UrologíaEnMovimiento

🦠What’s the role of #BCG in #NMIBC? 🗞️Contemporary review led by my great friend Óscar Rodríguez Faba in actasurologicas 🧐Detailed recommendations and future challenges ✍️Mario AlvarezMaestro MJLedo Joan Palou Redorta Jose Alvarez Ossorio among others 👓Read it: t.ly/UqlPo AEU

Extraordinaria experiencia participar como invitado al Congreso Anual de la Sociedad Filipina de Urología en Manila.

🔍 #Bladdercancer is highly treatable when caught early. Early detection can make a huge difference. Let’s spread the word and save lives! Learn more about prevention & treatment👉 ow.ly/rYgP50Rn5fo

Muchas gracias Alex Hermen y Antonio Herrera un placer haber participado del evento de del congreso.

Thanks to all the members of blatam uro After hard work, we managed to collect data from #LATAM on #NMIBC patients. There is still much to improve and correct in the region. UroToday.com OncoAlert Ashish M. Kamat, MD, MBBS IBCG Mario I Fernandez Oficina Residentes CAU urotoday.com/recent-abstrac…

Gustavo Villoldo blatam uro UroToday.com OncoAlert Ashish M. Kamat, MD, MBBS IBCG Oficina Residentes CAU Nice job Gustavo Villoldo and blatam uro. Relevant effort to show real world data in LATAM. And really concerning data about timing of therapy

🌎🤝 El estudio BLATAM revela brechas en el uso de BCG para cáncer de vejiga en LATAM. La clave: colaboración para mejorar la atención. 🔬💪 #BLATAM #Oncología #TrabajoEnEquipo pubmed.ncbi.nlm.nih.gov/39908205/ Gustavo Villoldo Martín Angel UroTarget UroToday.com Marco.Care

Gustavo Villoldo blatam uro UroToday.com OncoAlert Ashish M. Kamat, MD, MBBS IBCG Mario I Fernandez Oficina Residentes CAU Felicitaciones Gustavo y co autores! Grandes avances para Latam!

Arrancando #ASCO25 🇦🇷 presente! ⁦UroTarget⁩ ⁦Urooncologia.arg⁩ ⁦blatam uro⁩

Happy to share #GU25 with friends Channing Paller Juan Pablo Sade FLoscoMD DR CARVAJAL Gustavo Villoldo

Felicitaciones Danny Mena - nuclear medicine por la excelente presentación en #GU25 Gran representación de UroTeragLATAM

once again , a ph3 trial comfiming the prognostic factor of pCR!!! #NIAGARA #GU25 IntraMed Oncología blatam uro Andrea Necchi Matt Galsky

all #MIBC patients SHOULD BE offer neoadjuvant treatment Elizabeth Plimack MD #GU25 the conclusion ever!! IntraMed Oncología blatam uro

Ellegant presentation by Daniel Castellano ... Overcoming Challenges of Antibody-Drug Conjugate Toxicity in Bladder Cancer #GU25 IntraMed Oncología blatam uro GUARD Consortium ASCO Asociación Argentina de Oncología Clínica (AAOC) Fundación Cáncer

#ASCOGU25 Excelente presentación de un gran maestro Daniel Castellano 👏👏👏👏

Superstar Roger Li on role of ctDNA in UTUC; panning for gold #GU25

#GU25 ASCO Tom Powles presents the spectacular data from EV302 with median fu of 2.5 years. EV-pembrolizumab continues to show maintenance of significantly improved OS & PFS compared to platinum. DoR ~ 2 yrs & in pts with confirmed CR, probability to remain in CR at 2 yrs